| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 624512 | Null | 0.0100995289754787 | 0.67295103 |
| NSC 629910 | Null | 0.0100995289754787 | 0.19734179 |
| NSC 649307 | Null | 0.0100995289754787 | 0.29378689 |
| NSC 667707 | Null | 0.0100995289754787 | 0.068665334 |
| NSC 671392 | Null | 0.0100995289754787 | 0.42625467 |
| NSC 676779 | Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop | 0.0100995289754787 | 0.18648982 |
| NSC 678925 | 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride | 0.0100995289754787 | 0.32636607 |
| NSC 682764 | Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- | 0.0100995289754787 | -0.19478077 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.0100995289754787 | 0.32144458 |
| NSC 697166 | 4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- | 0.0100995289754788 | 0.25329585 |